Cary Street Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,493
Closed -$81.8K 930
2025
Q1
$81.8K Sell
5,493
-1,972
-26% -$30.3K ﹤0.01% 815
2024
Q4
$111K Buy
+7,465
New +$122K ﹤0.01% 772

Other funds holding OGN

Cary Street Partners's OGN Position: Q2 2025 in Review

Cary Street Partners sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 5,493 shares — an estimated $81.8K sold.

Cary Street Partners first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $111K in Q4 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Cary Street Partners reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Cary Street Partners sold 5,493 Organon & Co shares in Q2 2025, an estimated $81.8K.
  • Cary Street Partners first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
  • Cary Street Partners's Organon & Co position peaked at $111K in Q4 2024.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Cary Street Partners's 13F filing for Q2 2025, filed 13 Aug 2025.